209 related articles for article (PubMed ID: 16219554)
1. Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.
Della Porta MG; Malcovati L
Haematologica; 2005 Oct; 90(10):1298C. PubMed ID: 16219554
[No Abstract] [Full Text] [Related]
2. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplants for patients with acute leukemia and myelodysplastic syndrome using unrelated donors.
Messner HA
Transfus Sci; 1991; 12(3):151-3. PubMed ID: 10149544
[No Abstract] [Full Text] [Related]
4. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Alyea EP; Kim HT; Ho V; Cutler C; DeAngelo DJ; Stone R; Ritz J; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1047-55. PubMed ID: 17067911
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients.
Sutton L; Leblond V; Le Maignan C; Jouet JP; Kuentz M; Gluckman E; Blaise D; Marit G; Attal M; Troussard X
Bone Marrow Transplant; 1991; 7 Suppl 2():39. PubMed ID: 1878712
[No Abstract] [Full Text] [Related]
6. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
7. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
[TBL] [Abstract][Full Text] [Related]
8. Second allogeneic stem cell transplantation in myeloid malignancies.
Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia.
de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A
Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713
[No Abstract] [Full Text] [Related]
10. [Allogeneic bone marrow transplantation in adult patients with serious hematological diseases 1985-1992].
Brinch L; Evensen SA; Blomhoff JP; Albrechtsen D
Tidsskr Nor Laegeforen; 1993 Nov; 113(27):3351-3. PubMed ID: 8273060
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation.
Graef T; Vaupel M; Fenk R; Ruf L; Zohren F; Germing U; Haas R; Kobbe G
Hematol Oncol; 2007 Dec; 25(4):170-7. PubMed ID: 17579887
[TBL] [Abstract][Full Text] [Related]
12. Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation.
Michur H; Maślanka K; Szczepiński A; Mariańska B
Int J Lab Hematol; 2008 Dec; 30(6):519-25. PubMed ID: 18983304
[TBL] [Abstract][Full Text] [Related]
13. Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor.
Orciuolo E; Azzarà A; Bandini G; Galimberti S; Bonifazi F; Fazzi R; Petrini M
Bone Marrow Transplant; 2004 Apr; 33(8):859-61. PubMed ID: 14743194
[TBL] [Abstract][Full Text] [Related]
14. Fulminant myocarditis after allogeneic bone marrow transplantation: successful cytomegalovirus therapy and mechanical circulatory support for bridge to recovery.
Kataoka K; Takahashi T; Iwata H; Hangaishi A; Kumano K; Kurokawa M
Biol Blood Marrow Transplant; 2010 Jan; 16(1):129-30. PubMed ID: 20053334
[No Abstract] [Full Text] [Related]
15. Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.
Roos-Weil D; Nguyen S; Uzunov M; Bories D; Chapiro E; Nguyen-Khac F; Vernant JP; Dhédin N
Bone Marrow Transplant; 2010 Sep; 45(9):1471-3. PubMed ID: 20098458
[No Abstract] [Full Text] [Related]
16. [Improvement of diabetes insipidus after allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome].
Sato N; Takayama N; Kizaki M; Ikeda Y; Okamoto S
Rinsho Ketsueki; 2003 May; 44(5):318-22. PubMed ID: 12822406
[TBL] [Abstract][Full Text] [Related]
17. [Importance of cytogenetics in the study of acute non-lymphoblastic leukemias].
Prieto F; Badía L; Palau F; Beneyto M; Montero MR; Martínez-Castellano F
Sangre (Barc); 1991 Jun; 36(3):229-35. PubMed ID: 1948543
[No Abstract] [Full Text] [Related]
18. Severe vulgaris psoriatic patients with acute myelogenous leukaemia and resolution after allogeneic bone marrow transplantation/peripheral blood stem cell transplantation.
He YL; Lu XJ; Qiu JY; Zhu TJ
Chin Med J (Engl); 2005 May; 118(10):861-5. PubMed ID: 15989770
[No Abstract] [Full Text] [Related]
19. De novo acute myeloblastic leukemia with trilineage abnormalities and a t(3;12) in a child.
Hazard E; Bastard C; Callat MP; Schneider P; Vannier JP
Med Pediatr Oncol; 2003 Jun; 40(6):397-400. PubMed ID: 12692813
[No Abstract] [Full Text] [Related]
20. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
de Lima M; Giralt S
Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]